Asked by: Lord Watson of Wyre Forest (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government how many asthma reviews were conducted in England in each of the five most recent years for which figures are available.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Quality Outcomes Framework (QOF) ensures all general practitioner practices establish and maintain a register of patients with an asthma diagnosis in accordance with National Institute for Health and Care Excellence guidance. Part of this guidance includes the provision of an annual Asthma review. The QOF annual review indicator was introduced in 2020/21 and contains Asthma review data from the past two years. In 2020/21 there were 1,132,926 and in 2021/22 there were 1,964,234. The 2022/23 data is to be published in September.
Asked by: Lord Watson of Wyre Forest (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what was the annual expenditure on asthma reviews in England for each of the five most recent years for which figures are available.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England does not hold this information.
Asked by: Lord Watson of Wyre Forest (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government how many people waited for allergy testing for more than 12 weeks in each of the past 10 years.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
This information is not collected centrally.
Asked by: Lord Watson of Wyre Forest (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government how many preventable deaths occurred in each of the three most recent years for which figures are available, as a result of (1) failure to administer an adrenaline auto-injector, and (2) failure of an adrenaline auto-injector.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
Data on the number of preventable deaths which have occurred as a result of failure to administer an adrenaline auto-injector and failure of an adrenaline auto-injector are not collected by Medicines and Healthcare products Regulatory Agency (MHRA), as the Human Medicines regulations relate to pharmacovigilance of adverse drug reactions and medication errors resulting in adverse drug reactions. Anyone experiencing side effects with medicines is encouraged to report these to MHRA via Yellow Card.
Asked by: Lord Watson of Wyre Forest (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the Government's review of hospital food will include mental health hospitals.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
Mental health hospitals are included in the National Health Service hospital food review.
Asked by: Lord Watson of Wyre Forest (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when he plans to publish an update on progress made on the Sugar Reduction Programme.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
The publication date for the second progress report for the sugar reduction programme is yet to be agreed.
Asked by: Lord Watson of Wyre Forest (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will publish a list of medicines that are (a) not currently available and (b) in short supply in (i) the West Midlands and (ii) England and Wales.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
The Department receives regular reports from the pharmaceutical industry about issues which may potentially interrupt the supply of medicines that may affect United Kingdom patients and uses a host of tools to help mitigate and manage any issues. From January this year, it became a mandatory requirement that pharmaceutical companies must report this information to us in a timely manner.
The Department shares regular updates about impending and current medicine supply issues directly with the National Health Service and the devolved administrations and communicates with other networks including patient groups where appropriate. These communications include information about mitigation actions and management plans to ensure affected patients can be managed appropriately. The Department does not share this information publicly.
Asked by: Lord Watson of Wyre Forest (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of EU citizens working for the NHS in the West Midlands that have been granted settled status; and what proportion of those EU citizens this represents.
Answered by Chris Skidmore
Information about the number of European Union citizens working for the National Health Service, in the West Midlands or elsewhere, who have been granted settled status is not held centrally.
Asked by: Lord Watson of Wyre Forest (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of women that are currently prescribed HRT in (a) the West Midlands and (b) all other regions of England.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
Asked by: Lord Watson of Wyre Forest (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential benefits to public health of stopping the advertising of high sugar milk and milk-replacement products on public transport.
Answered by Seema Kennedy
The Department has not assessed the potential benefits to public health of stopping the advertising of high sugar milk and milk-replacement products on public transport.
As committed to in the second chapter of our childhood obesity plan, published in June 2018, the Department of Health and Social Care and the Department for Digital, Culture, Media and Sport have jointly consulted on introducing further advertising restrictions for products high in fat, sugar and salt (HFSS) on TV and online. As part of this consultation we invited views on whether the scope of this consultation should be extended to other forms of media and how HFSS products should be defined. We have received a high level of responses to the consultation and it is important we take the time to consider them carefully before we set out further action.